triazoles has been researched along with Malignant Neurilemmoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul Razak, A; Al-Ezzi, E; Bravetti, J; D'Angelo, SP; Gounder, M; Mazzocca, A; Vincenzi, B; Wang, H; Watson, G | 1 |
1 other study(ies) available for triazoles and Malignant Neurilemmoma
| Article | Year |
|---|---|
Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.
Topics: Active Transport, Cell Nucleus; Humans; Hydrazines; Nerve Sheath Neoplasms; Neurofibrosarcoma; Triazoles | 2021 |